» » Antioxidants and Cardiovascular Disease (Developments in Cardiovascular Medicine)

Free eBook Antioxidants and Cardiovascular Disease (Developments in Cardiovascular Medicine) download

by Martial G. Bourassa,Jean-Claude Tardif

Free eBook Antioxidants and Cardiovascular Disease (Developments in Cardiovascular Medicine) download ISBN: 0387295526
Author: Martial G. Bourassa,Jean-Claude Tardif
Publisher: Springer; 2nd edition (November 16, 2005)
Language: English
Pages: 494
Category: Medicine
Subcategory: Medicine
Size MP3: 1379 mb
Size FLAC: 1650 mb
Rating: 4.3
Format: docx azw mobi lit


It is written by recognized experts in the fields of atherosclerosis and antioxidants.

It is written by recognized experts in the fields of atherosclerosis and antioxidants. It should be of interest not only to academicians but also to practicing physicians.

Martial G. Bourassa, Jean-Claude Tardif. Download (pdf, 3. 3 Mb) Donate Read.

Antioxidants and Cardiovascular Disease. Part of the Developments in Cardiovascular Medicine book series (DICM, volume 258).

In humans, chronic oxidative stress often coupled with deficiency of antioxidant defenses is associated with the aging process and can lead to the development of. .Series: Developments in Cardiovascular Medicine 233. File: PDF, 1. 8 MB. Читать онлайн.

Major cardiovascular conditions in which oxidative damage has been strongly implicated include atherosclerosis, myocardial ischemia and reperfusion, coronary restenosis and congestive heart failure. Compelling evidence points to oxidative stress as an important trigger in the complex chain of events leading to atherosclerosis.

Jean-Claude Tardif, Martial G. Bourassa. Generation of oxidants or reactive oxygen species is a natural process of human biology. Mitochondrial respiration, phagocytic activity and cyclooxygenase activation are all essential processes of life, which also generate oxidative species.

Автор: Bourassa Martial . Tardif Jean-Claude Название: Antioxidants and Cardiovascular . Martial G. Bourassa, Jean-Claude Tardif (. Springer Science & Business Media, 2006 - 494 sayfa.

Developments in Cardiovascular Medicine. Article · January 2004 with 6 Reads. These genetic variants also influence susceptibility to diseases, responses to treatment and clinical outcome. How we measure 'reads'. The daunting challenge in the upcoming years is to identify the variants that have significant clinical impacts from those that impose no discernible effects.

Chronic oxidative stress is associated with the aging process and often leads to the development of disorders such as cancer and arterial disease. Cardiovascular conditions in which oxidation damage has been strongly implicated include atherosclerosis, myocardial ischemia and reperfusion, coronary restenosis, diabetes mellitus, and congestive heart failure.

Antioxidants and Cardiovascular Disease, Second Edition covers three major topics: 1) the first seven chapters review the oxidative modifcation hypothesis and its close relationship to lipid metabolism and to the pathogenesis of atherosclerosis; 2) the next four chapters describe the different compounds, nutrients and supplements with antioxidant properties and their mechanisms of action; 3) and finallly, the last ten chapters discuss the potential benefits of antioxidants in overall cardiovascular prevention, including hypertension, diabetes mellitus, dyslipidemias, and in the treatment and prevention of specific conditions such as chronic coronary artery disease, restenosis after percutaneous coronary intervention, and chronic heart failure.

Antioxidants and Cardiovascular Disease, Second Edition is written by recognized experts in the fields of atherosclerosis, heart failure and antioxidants. It should be of interest to medical students and fellows, researchers, and practicing physicians.

There has been rapid progress in our knowledge in this field during the last two to three years. Thus the current reedition appears timely. For instance, this second edition captures several recently reported and published clinical trials as welll as new information on diabetic and hypertensive cardiovascular disease.